Incidence of Acute Kidney Injury (AKI) in Critically Ill Patients Receiving Concomitant Vancomycin with Piperacillin-Tazobactam or Cefepime; a Systemic Review and Meta-analysis
Journal of Intensive Care Medicine · 2025
DOI: 10.1177/08850666251323265 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Lamees Alaradi und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Acute Kidney Injury, Vancomycin, Cefepime, Piperacillin, Tazobactam Drug Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Nephrotoxicity remains a significant concern in the management of critically ill patients receiving antibiotic therapy. The combination of Vancomycin and Piperacillin-Tazobactam (VPT) is frequently employed to combat multidrug-resistant infections. However, emerging evidence suggests a potential increase in the risk of acute kidney injury (AKI) associated with this combination. This study aims to systematically review and analyze the nephrotoxic risk of the VPT combination in comparison to Vancomycin with Cefepime (VC) combination therapy. Methodology: We conducted a systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search was performed in databases including PubMed and Google Scholar for studies published until 2024. Studies that reported AKI incidence in patients treated with VPT, or VC were included. The data were analyzed using random-effects models to estimate pooled incidence rates of AKI. Subgroup analyses were performed based on patient demographics and baseline renal function.
Results
A total of six studies involving 23 794 patients were included in the analysis. The pooled incidence of AKI in the VPT group was found to be 29.9% (95% CI: 25.3%-38.4%), significantly higher than that of the VC (22.7%) ( P < .05). A comparative analysis demonstrated a significantly higher risk of AKI in patients on VPT compared to VC (1.503; 95% CI: 1.221-1.849 P < .001).
Conclusion
The findings of this study underscore a significant increase in the risk of AKI associated with the Vancomycin and Piperacillin-Tazobactam combination in critically ill patients. Clinicians should exercise caution when prescribing this combination, particularly for patients with pre-existing renal dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Ibn Sina National College, Jeddah, Saudi Arabia.
- College of Medicine, University of Tabuk, Tabuk, Saudi Arabia.
- College of Medicine, Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia.
- College of Medicine, Taif University, Taif, Saudi Arabia.
- College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
ORCID-Profile: Lamees Alaradi, Nada Albariqi, Mona Alanazi, Naif Alghassab, Tief Aseri, Lujain Alahmadi, Ahmad Alahmadi, Yousef Alqarafi, Habeeba Bokhari
Zitieren
APA
Alaradi, L., Albariqi, N., Alanazi, M., Alghassab, N., Aseri, T., Alahmadi, L., Alahmadi, A., Althobaiti, A., Alqarafi, Y., Bokhari, H., Qutob, R. A., & Almaimani, M. (2025). Incidence of Acute Kidney Injury (AKI) in Critically Ill Patients Receiving Concomitant Vancomycin with Piperacillin-Tazobactam or Cefepime; a Systemic Review and Meta-analysis. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666251323265
Vancouver
Alaradi L, Albariqi N, Alanazi M, Alghassab N, Aseri T, Alahmadi L, et al. Incidence of Acute Kidney Injury (AKI) in Critically Ill Patients Receiving Concomitant Vancomycin with Piperacillin-Tazobactam or Cefepime; a Systemic Review and Meta-analysis. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666251323265
BibTeX
@article{Alaradi2025,
author = {Alaradi, Lamees and Albariqi, Nada and Alanazi, Mona and Alghassab, Naif and Aseri, Tief and Alahmadi, Lujain and Alahmadi, Ahmad and Althobaiti, Aseel and Alqarafi, Yousef and Bokhari, Habeeba and Qutob, Rayan A and Almaimani, Mohanad},
title = {Incidence of Acute Kidney Injury (AKI) in Critically Ill Patients Receiving Concomitant Vancomycin with Piperacillin-Tazobactam or Cefepime; a Systemic Review and Meta-analysis},
journal = {Journal of Intensive Care Medicine},
year = {2025},
doi = {10.1177/08850666251323265}
}
EUVIMED